Cargando…
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms
INTRODUCTION: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is an established treatment for pseudomyxoma peritonei (PMP) from perforated low-grade appendiceal mucinous neoplasms (LAMN II). In a selected group of LAMN II patients without established PMP, CRS/HIPEC c...
Autores principales: | Abudeeb, Haytham, Selvasekar, Chelliah R., O’Dwyer, Sarah T., Chakrabarty, Bipasha, Malcolmson, Lee, Renehan, Andrew G., Wilson, Malcolm S., Aziz, Omer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644477/ https://www.ncbi.nlm.nih.gov/pubmed/31993814 http://dx.doi.org/10.1007/s00464-019-07349-x |
Ejemplares similares
-
Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit
por: Bhutiani, Neal, et al.
Publicado: (2023) -
Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience
por: Santullo, Francesco, et al.
Publicado: (2021) -
Factors influencing long‐term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms
por: van Eden, W. J., et al.
Publicado: (2019) -
Repeat cytoreductive surgery with or without intraperitoneal chemotherapy for recurrent epithelial appendiceal neoplasms
por: Karpes, J. B., et al.
Publicado: (2020) -
RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases
por: Bhullar, Dilraj, et al.
Publicado: (2022)